Chinese team to launch first CRISPR trial

Next month, researchers in China expect be the first in the world to treat a patient using the gene-editing tool CRISPR, Nature reports today. A team at Sichuan University’s West China Hospital in Chengdu received regulatory approval on 6 July to launch a clinical trial for lung cancer that will involve deleting a gene in patient’s T cells, a type of immune cell, so the T cells will be better at fighting tumors. U.S. researchers are  planning a similar trial that involves more extensive DNA tweaks, but haven’t yet received all the necessary approvals.

Latest News